The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis

被引:0
|
作者
Di Castelnuovo, A
Burzotta, F
Marchioli, R
Donati, MB
Iacoviello, L
机构
[1] Catholic Univ Rome, Inst Cardiol, Rome, Italy
[2] Catholic Univ Rome, Dept Vasc Med & Pharmacol, Angela Valenti Lab Thrombosis Pharmacol, Ist Ric Farmacol Mario Negri,Unit Genet Vasc Risk, Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
206
引用
收藏
页码:S104 / S105
页数:2
相关论文
共 50 条
  • [1] The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis
    Iacoviello, L
    Burzotta, F
    Di Castelnuovo, A
    Zito, F
    Marchioli, R
    Donati, MB
    [J]. THROMBOSIS AND HAEMOSTASIS, 1998, 80 (06) : 1029 - 1030
  • [2] PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis
    Liang, Zhongshu
    Jiang, Weihong
    Ouyang, Mao
    Yang, Kan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 2097 - 2107
  • [3] PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction
    Leander, K
    Wiman, B
    Hallqvist, J
    Sten-Linder, M
    de Faire, U
    [J]. THROMBOSIS AND HAEMOSTASIS, 2003, 89 (06) : 1064 - 1071
  • [4] Diabetic microangiopathy and 4G/5G polymorphism of the PAI-1 gene promoter in IDDM
    Pucci, L
    Pilo, M
    Bandinelli, S
    Navalesi, R
    Penno, G
    [J]. DIABETES, 1999, 48 : A153 - A153
  • [5] 4G/5G polymorphism in the promoter region of the PAI-1 gene is not a risk factor for familial myocardial infarction in subjects over 45 years
    Burzotta, F
    DiCastelnuovo, A
    Amore, C
    DOrazio, A
    Donati, MB
    Iacoviello, L
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, 78 (04) : 1294 - 1295
  • [6] Relation between osteonecrosis of the femoral head and PAI-1 4G/5G gene polymorphism: a meta-analysis
    Zeng, Zheng
    Wang, Bing
    Pan, Haitao
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 20337 - 20342
  • [7] The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women
    Hindorff, LA
    Schwartz, SM
    Siscovick, DS
    Psaty, BM
    Longstreth, WT
    Reiner, AP
    [J]. JOURNAL OF CARDIOVASCULAR RISK, 2002, 9 (02): : 131 - 137
  • [8] An alternative method for PAI-1 promoter polymorphism (4G/5G) typing
    Margaglione, M
    Grandone, E
    Cappucci, G
    Colaizzo, D
    Giuliani, N
    Vecchione, G
    dAddedda, M
    DiMinno, G
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, 77 (03) : 605 - 606
  • [9] The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis
    Nikolopoulos, Georgios K.
    Bagos, Pantelis G.
    Tsangaris, Iraklis
    Tsiara, Chrissa G.
    Kopterides, Petros
    Vaiopoulos, Aristides
    Kapsimali, Violetta
    Bonovas, Stefanos
    Tsantes, Argirios E.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (07) : 937 - 950
  • [10] PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
    Wang, Shangqian
    Cao, Qiang
    Wang, Xiaoxiang
    Li, Bingjie
    Tang, Min
    Yuan, Wanqing
    Fang, Jianzheng
    Qian, Jian
    Qin, Chao
    Zhang, Wei
    [J]. PLOS ONE, 2013, 8 (02):